Lucas Montarce
Chief Financial Officer, Eli Lilly and Company.
Companies
- Eli Lilly and CompanyChief financial officer Sep 18, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY16,258 shares2$20.4M at $1,257.32Feb 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 16, 2026Shares withheld for tax 160 shares at $1,040.00 of Eli Lilly and Company2
- Feb 16, 2026Exercised options 368 shares of Eli Lilly and Company2
- Feb 9, 2026Granted 1,365 shares at $1,044.67 of Eli Lilly and Company3
- Aug 15, 2025Bought 715 shares at $691.79 of Eli Lilly and Company4
- Feb 10, 2025Granted 2,896 shares at $868.88 of Eli Lilly and Company5
- Nov 1, 2024Shares withheld for tax 467 shares at $818.93 of Eli Lilly and Company6
- Nov 1, 2024Exercised options 1,074 shares of Eli Lilly and Company6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 11, 2026
- 4SEC EDGARForm 4 filed Aug 15, 2025
- 5SEC EDGARForm 4 filed Feb 12, 2025
- 6SEC EDGARForm 4 filed Nov 5, 2024